✦ LIBER ✦

Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study

✍ Scribed by I. Mahé; J. F. Bergmann; P. d’Azémar; J. J. Vaissie; C. Caulin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of a low-molecular-weight heparin

✍ E.M. Pogliani; M. Salvatore; I. Baragetti; P.G. Settembrini; G. Pezzuoli; E.E. P 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Low molecular-weight heparin versus aspi

✍ E Berge; M Abdelnoor; PH Nakstad; PM Sandset 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 107 KB

The use of low molecular weight heparin

✍ David Dix; Maureen Andrew; Velma Marzinotto; Karen Charpentier; Suzanne Bridge; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 936 KB

Pharmacokinetic Profile of a Low-Molecul

✍ Mark A Crowther; Karen Spitzer; Jim Julian; Jeff Ginsberg; Marilyn Johnston; Rob 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Pharmacodynamics of low molecular weight

✍ Davide Imberti; Cristina Legnani; Edoardo Baldini; Michela Cini; Alberto Nicolin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 271 KB

A randomised double-blind placebo contro

✍ Robert F. Burrows; Eng T. Gan; Alexander S. Gallus; Euan M. Wallace; Elizabeth A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB